08HH fundamentals
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of 08HH for the last semiannual is 2.50 B EUR, and it's 11.41% lower compared to the previous semiannual. The net income of H2 23 is 77.06 M EUR.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM